No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BIIB241220C120000
- 0.00
- 0.000.00%
15min DelayTrading Dec 16 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest120.00Strike Price0.00Turnover0.00%IV-20.61%PremiumDec 20, 2024Expiry Date31.15Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.88Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Netflix, Ford, Biogen: Trending Tickers
Stifel Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $175
Stifel Downgrades Biogen to Hold From Buy, Adjusts Price Target to $175 From $275
Palantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped.
Biogen Stock Touches 52-week Low at $153.55 Amid Challenges
Biogen ALS Drug Needs to Be Covered by MA Plans, CMS Says